Hyperbaric oxygen therapy reduces the size of Leishmania amazonensis-induced soft tissue lesions in mice

Acta Tropica

Volumn 98, Issue 2, 2006, Pages 130-136

  Arrais Silva, Wagner Welber ^a   Pinto, Eduardo Fonseca ^b   Rossi Bergmann, Bartira ^b   Giorgio, Selma ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Hyperbaric oxygen; Leishmania amazonensis; Leishmaniasis

Indexed keywords

CONCANAVALIN A; GAMMA INTERFERON; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

DISEASE CONTROL; INOCULATION; LESION; PARASITIC DISEASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HYPERBARIC OXYGEN; IMMUNE RESPONSE; INOCULATION; LEISHMANIA; LEISHMANIASIS; LYMPH NODE; MOUSE; NONHUMAN; PARASITE CONTROL; PROTEIN BLOOD LEVEL; SOFT TISSUE DEFECT; SOFT TISSUE INFECTION; TH1 CELL; TREATMENT OUTCOME;

ANIMALS; FEMALE; HISTOCYTOCHEMISTRY; HYPERBARIC OXYGENATION; INTERFERON TYPE II; INTERLEUKIN-10; LEISHMANIA; LEISHMANIASIS; LYMPH NODES; MICE; MICE, INBRED BALB C; SOFT TISSUE INFECTIONS; TUMOR NECROSIS FACTOR-ALPHA;

LEISHMANIA AMAZONENSIS;

EID: 33646888866     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2006.03.001     Document Type: Article

References (38)

1. Arrais-Silva W.W., Colhone M.C., Ayres D.C., Souto P.C.S., and Giorgio S. Effects of hyperbaric oxygen on Leishmania amazonensis promastigotes and amastigotes. Parasitol. Int. 54 (2005) 1-7
2. Arrais-Silva W.W., Paffaro Jr. V.A., Yamada A.T., and Giorgio S. Expression of hypoxia-inducible factor-1alpha in the cutaneous lesions of BALB/c mice infected with Leishmania amazonensis. Exp. Mol. Pathol. 78 (2005) 49-54
3. Barbiéri C.L., Giorgio S., Merjan A.J.C., and Figueiredo E.N. Glycosphingolipid antigens of Leishmania (Leishmania) amazonensis identified by use of a monoclonal antibody. Infect. Immun. 61 (1993) 2131-2137
4. Barral-Netto M., Cardoso S.A., and Barral A. Different patterns of disease in two inbred mouse strains infected with a clone of Leishmania mexicana amazonensis. Acta Trop. 44 (1987) 5-11
5. Benson R.M., Minter L.M., Osborne B.A., and Granowitz E.V. Hyperbaric oxygen inhibits stimulus-induced proinflammatory cytokine synthesis by human blood-derived monocyte-macrophages. Clin. Exp. Immunol. 134 (2003) 57-62
6. Berman J. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin. Infect. Dis. 24 (1997) 684-703
7. Berman J.D. Current treatment approaches to leishmaniasis. Curr. Opin. Infect. Dis. 16 (2003) 397-401
8. Beyrodt C.G., Pinto A.R., Freymuller E., and Barbieri C.L. Characterization of an antigen from Leishmania amazonensis amastigotes able to elicit protective responses in a murine model. Infect. Immun. 65 (1997) 2052-2059
9. Brenner I., Shephard R.J., and Shek P.N. Immune function in hyperbaric environments, diving, and decompression. Undersea Hyperb. Med. 26 (1999) 27-39
10. Bretscher P.A., Wei G., Menon J.N., and Bielefeldt-Ohmann H. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science 257 (1992) 539-542
11. Campbell K., Diao H., Ji J., and Soong L. DNA immunization with the gene encoding P4 nuclease of Leishmania amazonensis protects mice against cutaneous leishmaniasis. Infect. Immun. 71 (2003) 6270-6278
12. Chen S.Y., Chen Y.C., Wang J.K., Hsu H.P., Ho P.S., Chen Y.C., and Sytwu H.K. Early hyperbaric oxygen therapy attenuates disease severity in lupus-prone autoimmune (NZB × NZW) F1 mice. Clin. Immunol. 108 (2003) 103-110
13. Clark L., and Monn R.E. Hyperbaric oxygen in the treatment of life-threatening soft-tissue infections. Respir. Care Clin. N. Am. 5 (1999) 203-219
14. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp. Immunol. Microbiol. Infect. Dis. 27 (2004) 305-318
15. Doherty T.M., and Coffman R.L. Leishmania major: effect of infectious dose on T cell subset development in BALB/c mice. Exp. Parasitol. 84 (1996) 124-135
16. El-On J., Sneier R., and Elias E. Leishmania major: bacterial contamination of cutaneous lesions in experimental animals. Isr. J. Med. Sci. 28 (1992) 81-85
17. Giorgio S., Linares E., Ischiropoulos H., Von Zuben F.J., Yamada A., and Augusto O. In vitro formation of electron paramagnetic resonance-detectable nitric oxide and nitrotyrosine is not impaired during murine leishmaniasis. Infect. Immun. 66 (1998) 807-814
18. Gonçalves G.S., Fernandes A.P., Souza R.C., Cardoso J.E., de Oliveira-Silva F., Maciel F.C., Rabello A., and Ferreira L.A. Activity of a paromomycin hydrophilic formulation for topical treatment of infections by Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis. Acta Trop. 93 (2005) 161-167
19. Granowitz E.V., Skulsky E.J., Benson R.M., Wright J., Garb J.L., Cohen E.R., Smithline E.C., and Brown R.B. Exposure to increased pressure or hyperbaric oxygen suppresses interferon-gamma secretion in whole blood cultures of healthy humans. Undersea Hyperb. Med. 29 (2002) 216-225
20. Grimaldi Jr. G., and Tesh R.B. Leishmaniasis of the new world: current concepts and implications for future research. Clin. Microbiol. Rev. 6 (1993) 230-250
21. Handman E. Leishmaniasis: current status of vaccine development. Clin. Microbiol. Rev. 14 (2001) 229-243
22. Herwaldt B.L. Leishmaniasis. Lancet 354 (1999) 1191-1199
23. Inamoto Y., Okuno F., Saito K., Tanaka Y., Watanabe K., Morimoto I., Yamashita U., and Eto S. Effect of hyperbaric oxygenation on macrophage function in mice. Biochem. Biophys. Res. Commun. 179 (1991) 886-891
24. Khaskhely N.M., Maruno M., Takamiyagi A., Uezato H., Kasem K.M., Hosokawa A., Kariya K., Hashiguchi Y., Landires E.A., and Nonaka S. Pre-exposure with low-dose UVA suppresses lesion development and enhances Th1 response in BALB/c mice infected with Leishmania (Leishmania) amazonensis. J. Dermatol. Sci. 26 (2001) 217-232
25. Khaskhely N.M., Maruno M., Uezato H., Takamiyagi A., Ramzi S.T., Al-Kasem K.M., Kariya K., Toda T., Hashiguchi Y., Gomez Landires E.A., and Nonaka S. Low-dose UVB contributes to host resistance against Leishmania amazonensis infection in mice through induction of gamma interferon and tumor necrosis factor alpha cytokines. Clin. Diagn. Lab. Immunol. 9 (2002) 677-686
26. La Van F.B., and Hunt T.K. Oxygen and wound healing. Clin. Plastic Surg. 17 (1990) 463-472
27. Lahat N., Bitterman H., Yaniv N., Kinarty A., and Bitterman N. Exposure to hyperbaric oxygen induces tumor necrosis factor-alpha (TNF-α) secretion from rat macrophages. Clin. Exp. Immunol. 102 (1995) 655-659
28. Leach R.M., Rees P.J., and Wilmshurst P. Hyperbaric oxygen therapy. Br. Med. J. 317 (1998) 1140-1143
29. Luongo C., Imperatore F., Cuzzocrea S., Filippelli A., Scafuro M.A., Mangoni G., Portolano F., and Rossi F. Effects of hyperbaric oxygen exposure on a zymosan-induced shock model. Crit. Care Med. 26 (1998) 1972-1976
30. Macharia J.C., Bourdichon A.J., and Gicheru M.M. Efficacy of trypan: a diminazene based drug as antileishmanial agent. Acta Trop. 92 (2004) 267-272
31. Park M.K., Myers R.A.M., and Marzella I. Oxygen tensions and infections: modulation of microbial growth, activity of antimicrobial agents and immunological responses. Clin. Infect. Dis. 14 (1992) 720-740
32. Pinheiro R.O., Pinto E.F., Benedito A.B., Lopes U.G., and Rossi-Bergmann B. The T-cell anergy induced by Leishmania amazonensis antigens is related with apoptosis and defective antigen presentation. Anais Acad. Bras. Ciências 76 (2004) 519-527
33. Pinto E.F., de Mello Cortezia M., and Rossi-Bergmann B. Interferon-gamma-inducing oral vaccination with Leishmania amazonensis antigens protects BALB/c and C57BL/6 mice against cutaneous leishmaniasis. Vaccine 21 (2003) 3534-3541
34. Scott P., Artis D., Uzonna J., and Zaph C. The development of effector and memory T cells in cutaneous leishmaniasis: the implications for vaccine development. Immunol. Rev. 201 (2004) 318-338
35. Sitkovsky M.V., Lukashev D., Apasov S., Kojima H., Koshiba M., Caldwell C., Ohta A., and Thiel M. Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu. Rev. Immunol. 22 (2004) 657-682
36. Smith R.M., and Mohideen P. One hour in 1 ATA oxygen enhances rat alveolar macrophage chemiluminescence and fungal cytotoxicity. Am. J. Physiol. 260 (1991) L457-L463
37. Taha S.M., and Tabbara K.S. Modulation of the immune response of Balb/c mice against Leishmania major by imuvert. Int. J. Immunopharmacol. 19 (1997) 443-449
38. Tandara A.A., and Mustoe T.A. Oxygen in wound healing-more than a nutrient. World J. Surg. 28 (2004) 294-300